autologous human tumor-derived hsppc-96
Cell therapyexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2000 (NCT00081809)
Timeline
Indications
Mechanism of action
- Unspecified targetSupplementation
supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous human tumor-derived hsppc-96
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00082459 | Phase 2 | Jul 1, 2002 | Agenus Inc. |
| NCT00033904 | Phase 3 | Jun 1, 2000 | Agenus Inc. |
| NCT00081809 | Phase 2 | Mar 1, 2000 | Agenus Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Agenus Inc. | For profit | 3 | 3 | 2 | 2000 |
1 organizations
Page 1 / 1